Inhibiting breast cancer by targeting the thromboxane A(2) pathway

Targeting the estrogen receptor as a strategy has been the gold standard for breast cancer chemoprevention or breast cancer recurrence, but its benefit is limited to estrogen receptor-positive tumors. Cyclooxygenases have been implicated in mammary tumorigenesis. We sought to identify the key prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Haitao, Lee, Mee-Hyun, Liu, Kangdong, Wang, Ting, Song, Mengqiu, Han, Yaping, Yao, Ke, Xie, Hua, Zhu, Feng, Grossmann, Michael, Cleary, Margot P., Chen, Wei, Bode, Ann M., Dong, Zigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859468/
https://www.ncbi.nlm.nih.gov/pubmed/29872696
http://dx.doi.org/10.1038/s41698-017-0011-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859468/
https://www.ncbi.nlm.nih.gov/pubmed/29872696
http://dx.doi.org/10.1038/s41698-017-0011-4

Ejemplares similares